July 4, 2011

Comparison of radio-frequency ablation and trans-arterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

The number of liver transplants for hepatocellular carcinoma (HCC) is significantly increasing. Several modalities have been described for the treatment of HCC including radiofrequency ablation (RFA) and trans-arterial chemoembolization (TACE). These modalities can be used as a bridge to liver transplant, or a final treatment in and of themselves.  In this single-center retrospective study, the authors compared long-term outcome of HCC patients who underwent RFA or TACE. Long-term survival was similar with either treatment, but there may be a subgroup which benefits more from RFA.

 

Liver Transplantation

Tags: , , ,